Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
19
20
22
23
24
25
26
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
AHIMA25  Conference
2025-10-12 - 2025-10-14    
9:00 am - 10:00 pm
Register for AHIMA25  Conference Today! HI professionals—Minneapolis is calling! Join us October 12-14 for AHIMA25 Conference, the must-attend HI event of the year. In a city known for its booming [...]
Federal EHR Annual Summit
2025-10-21 - 2025-10-23    
9:00 am - 10:00 pm
The Federal Electronic Health Record Modernization (FEHRM) office brings together clinical staff from the Department of Defense, Department of Veterans Affairs, Department of Homeland Security’s [...]
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Events on 2025-10-05
Events on 2025-10-12
AHIMA25  Conference
12 Oct 25
Minnesota
Events on 2025-10-21
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN

Events

Latest News

UK government releases details of COVID-19 data-sharing deals with big tech firms after legal action threat

healthcare

Contracts released by the UK government have revealed that personal health information about millions of NHS patients was provided to private tech firms involved in the COVID-19 datastore project. The project announced in March intended to collate data from health and social care organisations in order to “provide a single source of truth” about the pandemic.

However there were concerns about privacy issues, with MPs asking questions in parliament about the deals with private firms and more than 13,000 people joining a call for transparency.  Political website openDemocracy and tech justice firm Foxglove sent legal letters demanding transparency about the agreements, which were revealed hours before court proceedings were due to start on 5 June. Details of the deals with Google, Amazon, Microsoft and Palantir and Faculty have been published online by openDemocracy.

They reveal that companies involved in the datastore project were originally granted intellectual property rights and allowed to train their models and profit from access to NHS data, but the terms of the deal were changed after a Freedom of Information request made by Foxglove.

The Faculty contract shows that the firm, which has been linked to Dominic Cummings – the Prime Minister’s chief adviser, is being paid more than £1 million to provide artificial intelligence (AI) services for the NHS.

WHY IT MATTERS 

An NHS blog announcing the datastore project, had ensured privacy, stating that  “essential data governance procedures and established principles of openness and transparency remain at the core of everything we do”; that the data collected “will only be used for COVID-19”; and that “only relevant information will be collected.”

It also said that “once the public health emergency situation has ended, data will either be destroyed or returned in line with the law and the strict contractual agreements that are in place between the NHS and partners”.

THE LARGER CONTEXT 

Campaigning organisations, Privacy International and the Open Rights Group previously issued a statement raising concerns about the involvement of Palantir, flagging up the firm’s past work on the tracking of migrants and provision of espionage tools.

ON THE RECORD

Foxglove founding director Cori Crider and openDemocracy editor-in-chief Mary Fitzgerald wrote in a blog post: “The contracts show that the companies involved, including Faculty and Palantir, were originally granted intellectual property rights (including the creation of databases), and were allowed to train their models and profit off their unprecedented access to NHS data.”

A Faculty spokesperson said the company “asked for its contract to be amended to make clear that it will derive no commercial benefit from any software, including trained machine learning models, developed during the course of the project and that the use of the IP is under the sole control of the NHS”.